Kythera Biopharmaceuticals, Inc

Kythera Biopharmaceuticals, Inc

KYTHERA Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic medicine market. KYTHERA’s lead product, KYBELLA™, is the first and only approved non-surgical...
Qwixel Therapeutics

Qwixel Therapeutics

Qwixel Therapeutics addresses the need to develop therapeutics to treat multiple myeloma (MM), a B cell cancer disease that is not curable. Market:The anti-CD138 fused with Interferon (IFN) will both directly kill the malignant cells and will help boost the immune...